|
||
|
Segmentation of GLD in terms of full and partial reimbursement for 2021–2022. |
|
||||||||
| Part of: Vlasenko I, Davtian L (2023) Study of the influence of armed conflict on the reimbursement of oral glucose lowering drugs in Ukraine. Pharmacia 70(2): 275-281. https://doi.org/10.3897/pharmacia.70.e99657 |